No 10Y consistency score yet for revenue — the window needs more comparable quarters.
Valuation vs own 10Y history: P/S 1.1x · 10Y median 1.1x · 38th percentile · as of Oct 6, 2026
Annual revenue · last 4 fiscal years + TTM
Quarterly YoY revenue growth vs the 20% line
P/S multiple vs its 10Y median
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Unrounded diluted TTM EPS / FMP quote price × 100. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05.
Four-quarter operating EBITDA / current FMP quote-based enterprise value × 100. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter operating cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
Four-quarter free cash flow / FMP quote market capitalization × 100. Quote observation: 2026-10-06T14:01:56.496Z. Latest historical point 2026-10-05. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
The latest delayed quote for HMH Holding Inc. Class A Common Stock (HMH) stock was $18.83 as of Oct 6, 2026, 10:00 AM EDT, down 1.82% from the previous close.
HMH Holding Inc. specializes in delivering essential, purpose-built equipment solutions critical for both offshore and onshore oil and natural gas extraction.
Oil & Gas Equipment & Services · Houston, TX
LATEST PRICE
$18.83
52-WEEK RANGE
$16.32 - $24.50
BETA
0.78
% FROM 52W HIGH
-23.14%
MARKET CAP
$841.48M
DIVIDEND YIELD
Never paid
N/A
PE RATIO
trailing TTM
21.44
PE RATIO (FWD)
forward FY estimate
12.30
P/B RATIO
4.00
P/S RATIO
TTM
1.10
P/OCF RATIO
TTM
6.95
EV/EBITDA
TTM
7.22
DEBT / EQUITY
1.17
REVENUE TTM
$762.01M
GROSS MARGIN TTM
33.24%
NET PROFIT MARGIN TTM
5.09%
REVENUE GROWTH TTM
TTM vs prior TTM
-9.71%
REVENUE CAGR 3Y
+6.66%
REVENUE CAGR 5Y
N/A
TTM TOTAL RETURN
N/A
3Y TOTAL RETURN
annualized (CAGR)
N/A
5Y TOTAL RETURN
annualized (CAGR)
N/A
Next Earnings Date
Dec 2, 2026
57 days away
EPS Estimate
0.70
Revenue Est.
$214.59M
Last Quarter Results
EPS
$0.26
vs Estimate
$0.27
Revenue
$170.82M
vs Estimate
$189.57M
Consensus Rating
Based on 7 analysts
Average Price Target
$28.71
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $0.67 | $0.70 | $0.74 | 2 |
| Quarter ending Dec 2026 | $0.92 | $0.93 | $1.02 | 2 |
| Quarter ending Mar 2027 | $0.68 | $0.73 | $0.80 |
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR | Compare |
|---|---|---|---|---|---|---|---|
| 1HMH | $841.48M | $18.83 | -1.82% | N/A | N/A | N/A | N/A |
| 2ACDC | $873.85M | $4.83 | +1.68% | +13.84% | N/A | N/A | vs HMH |
| 3CSIQ | $788.28M | $11.61 | +3.75% | -26.27% | -19.00% | -2.70% | vs HMH |
| 4HPK | $989.38M | $7.83 | -3.21% | +12.79% | -4.76% | N/A | vs HMH |
| 5ARRY | $620.69M | $4.04 | +3.46% | -56.83% | -25.40% | N/A | vs HMH |
| 6METC | $428.72M | $7.97 | -0.34% | -78.65% | -8.04% | N/A | vs HMH |
+52.5% upside
Low
$24.00
Current
$18.83
High
$32.00
| 1 |
| Quarter ending Jun 2027 | $0.69 | $0.75 | $0.81 | 1 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $1.47 | $1.53 | $1.58 | 2 |
| FY 2027 | $2.13 | $2.18 | $2.24 | 3 |
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Quarter ending Sep 2026 | $202.12M | $214.59M | $222.38M | 4 |
| Quarter ending Dec 2026 | $224.27M | $239.55M | $254.40M | 4 |
| Quarter ending Mar 2027 | $212.15M | $225.72M | $241.42M | 2 |
| Quarter ending Jun 2027 | $217.63M | $231.56M | $247.66M | 2 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2026 | $765.55M | $800.23M | $819.13M | 5 |
| FY 2027 | $930.96M | $947.91M | $957.80M | 5 |
Source: FMP Analyst Consensus Estimates. Forward P/E uses the consensus EPS estimate for the fiscal year ending Dec 31, 2026, matching Key Metrics.
